Document is current

Article History

Received: 25 November 2024

Revised: 25 March 2025

Accepted: 2 April 2025

First Online: 19 April 2025

Declarations

:

: Dr. Elbuluk has served as a consultant, advisory board member, and/or speaker for Avita, Incyte, VisualDx, La Roche Posay, Beiersdorf, Allergan, Eli Lilly, Galderma, Pfizer, Takeda, Abbvie, Janssen, Sanofi, L’Oreal, McGraw Hill, Dior, Medscape, and Canfield. She has grant funding from Pfizer, has received royalties from McGraw-Hill and has stock options in VisualDx. Dr. Taylor has been a speaker for Beiersdorf, LivDerm, L'Oreal USA, MedScape, and MJH LifeSciences. She is on the advisory board for Abbvie, Arcutis, Avita Medical, Beiersdorf, Biorez, Bristol Myers Squibb, Cara Therapeutics, Dior, Eli Lilly, EPI Health, Evolus, Galderma, Hugel, J&J, L’Oreal USA, MedScape, Pfizer, Regeneron/Sanofi, Scientis US, UCB, and Vichy. She is a board member for Mercer Strategies. She has received royalties from McGraw-Hill book royalties. She does contracted research with Allergan Aesthetics, Concert Pharmaceuticals, Croma-Pharma GmbH, Eli Lilly, Pfizer. She has ownership interest in Armis Scientific, GloGetter, and Piction Health. The remaining authors have no disclosures to report.

: None.

: Not applicable.